Previous close | 6.01 |
Open | 6.04 |
Bid | 6.00 x 100 |
Ask | 8.00 x 100 |
Day's range | 6.35 - 6.35 |
52-week range | 5.12 - 6.90 |
Volume | |
Avg. volume | 4,353 |
Market cap | 38.57M |
Beta (5Y monthly) | 0.13 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.27 |
Earnings date | 26 Sept 2024 - 30 Sept 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
GARDNER, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the appointment of Clay Schwabe, as the Company’s Vice President of Sales and Marketing. Mr. Schwabe has over fifteen years of experience in medical device market access, sales, sales management, global product marketing, and commercialization. He is an emerging technologies
GARDNER, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that Dr. Joe Forkey, Chief Executive Officer, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024. Company WebcastThe webcasted presen
Discover how POCI achieved a record engineering revenue and improved financial metrics amidst strategic expansions and market challenges.